Active SanctionorganizationID: trade-csl-7e3c3cbd0366d0f705b9121480fb53637efc6f028b91dab56b46592f
Wuhan Institute of Biological Products Co., Ltd.
Primary Source
US TRADE CSL
Coverage
cn
Risk Tier
Critical
Last Updated
2026-07-26
Compliance Profile
"Risk Advisory: Records indicate that Wuhan Institute of Biological Products Co., Ltd. is associated with US TRADE CSL. Source-list verification is recommended."
Banking Impact
Due to designation on US TRADE CSL, processing any financial operations for this counterparty poses severe compliance risks, including secondary sanctions and asset forfeiture.
Legal Status
Strict embargo applies to commercial engagement. Any attempted contracts or supply chain interactions must be scrutinized against statutory prohibitions.
Official Source Metadata
Source: Multi-Source Risk Profile| Full Legal Name | Wuhan Institute of Biological Products Co., Ltd. |
| Source Records | US TRADE CSL |
| Enforcement Type | Multi-Source Risk Profile |
| Risk Topics | sanction, export.control, maritime |
Compliance Context Review
Independent Risk Assessment
SIC Group prepares source-backed risk context, exposure memos, and remediation pathways for entities seeking to clarify a public record or counterparty signal.
Source-list verification
Banking and counterparty exposure memo
Regulatory status and remediation triage
Confidential Review
Export PDFSubscriber Only